First reported at 1,150,000 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 22931000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 1,150,000 | +1,150,000 (0.0%) | 1.02% | $22,931,000 | 2026-11-16 |
Who else reported the position
62 managers reported ADARX PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | New | 24,205,789 | +24,205,789 | 8.81% | $482,663,433 | 1 qtr |
| SR ONE CAPITAL MANAGEMENT LP | New | 9,936,661 | +9,936,661 | 17.24% | $198,137,020 | 1 qtr |
| Bain Capital Life Sciences Investors LLC | New | 6,728,970 | +6,728,970 | 9.01% | $134,175,662 | 1 qtr |
| TCG Crossover Management LLC | New | 4,116,452 | +4,116,452 | 2.32% | $82,082,053 | 1 qtr |
| FMR LLC | New | 3,646,090 | +3,646,090 | < 0.01% | $72,703,035 | 1 qtr |
| PRICE T ROWE ASSOCIATES INC MD | New | 2,894,396 | +2,894,396 | < 0.01% | $57,715,000 | 1 qtr |
| BlackRock Inc | New | 2,336,110 | +2,336,110 | < 0.01% | $46,582,032 | 1 qtr |
| Capital International Investors | New | 2,132,301 | +2,132,301 | < 0.01% | $42,518,082 | 1 qtr |
| Siren L L C | New | 1,925,794 | +1,925,794 | 0.91% | $38,400,332 | 1 qtr |
| ALLIANCEBERNSTEIN L P | New | 1,719,816 | +1,719,816 | 0.01% | $34,293,131 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM ADDED
Voting authority reported
- Sole
- 1,150,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.